In a world that chases fitness and wellness amidst the hustle of daily lives, weight loss jabs have become the magic pills ...

Gordon Ramsay shared his thoughts on whether he’d adjust the menus at his restaurants to accommodate people taking ...

U.S. pharmaceutical giant Pfizer signed a deal to purchase development-stage obesity drugmaker Metsera Inc., winning a bidding war against Novo Nordisk, the Danish drugmaker behind weight-l ...

Scientists say they've come up with a way for the body to produce its own store of glucagon-like peptide-1 (GLP-1).

Insurance data reveals dramatic regional differences in Ozempic and Mounjaro usage, with obesity-heavy states prescribing GLP ...

James Austin Johnson as Trump also touched on the ongoing government shutdown, the suspension of SNAP benefits, and soaring food prices.

Three new Cochrane reviews find evidence that GLP-1 drugs lead to clinically meaningful weight loss, though industry-funded ...

Drugs like Ozempic, known collectively as GLP-1 receptor agonists, have become more widely used in recent years. Though they ...

Savannah Chrisley shared that she plans to begin using a GLP-1 medication to help her lose 25 pounds after previously trying ...

Friday on the RealClearPolitics podcast, Tom Bevan, Carl Cannon, and Andrew Walworth discuss whether anyone is in a position ...

Pfizer has signed a deal to purchase Metsera Inc., an obesity drugmaker in the development stage, after winning a bidding war ...